APA (7th ed.) Citation

Mary Clark, M., Paul Imbriano, D., Michael Harwood, M., Klaus Busam, M., & Leslie Robinson-Bostom, M. (2022). A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib. Elsevier.

Chicago Style (17th ed.) Citation

Mary Clark, MD, DO Paul Imbriano, MD Michael Harwood, MD Klaus Busam, and MD Leslie Robinson-Bostom. A Diagnostic Dilemma: Atypical Melanocytic Lesions Arising in the Setting of Treatment with the BRAF Inhibitor, Vemurafenib. Elsevier, 2022.

MLA (9th ed.) Citation

Mary Clark, MD, et al. A Diagnostic Dilemma: Atypical Melanocytic Lesions Arising in the Setting of Treatment with the BRAF Inhibitor, Vemurafenib. Elsevier, 2022.